FDA Approved: EZETIMIBE — Supplemental Application (ScieGen Pharmaceuticals Inc)

View source ↗

Summary

The FDA approved a supplemental application for ezetimibe by ScieGen Pharmaceuticals Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerotic Cardiovascular Disease
• Hypercholesterolemia
• Hyperlipidemia

Drugs mentioned

• EZETIMIBE (EZETIMIBE)

Snippet

SUPPL AP for EZETIMIBE (EZETIMIBE)